http://micar21.com/ 2019-03-20T06:59:45+00:00 1.00 http://micar21.com/Drug-Discovery-Services-Prices 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Drug-Discovery-Receptor-structure-generation-and-refinement 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Drug-Discovery-Hit-Identification 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Drug-Discovery-Lead-Optimization 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Changes-in-the-ligand-binding-affinity-and-selectivity-introduced-by-point-mutations 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/identification-of-P-glycoprotein-binders 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Discovery-of-novel-active-substances-medicinal-cosmetics-development 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Pipeline 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Company 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/About-us 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/management-team 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/management-team-filip-fratev 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/management-team-dimitar-dimitrov 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/management-team-elina-mihaylova 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/management-team-miguel-rivera 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/partners 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/business_model 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/careers 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/contact-us 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Innovative-technology 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Innovative-drug-design 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Innovative-genome-analysis 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/difference-between-technologies 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/our-in-silico-drug-design 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/in-silico-drug-design-scientific-information 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/genetics-screen-analysis 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/personalized-genetics-screen-analysis 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/personalized-genetics-screen-analysis-scientific-information 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/FAQ-personalized-genetics-screen-analysis 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/spin_out 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/news 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/company-news 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/discovery-of-novel-active-substances-for-medicinal-cosmetics-development 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Why-Should-Cardiologists-Consider-Genetic-Testing-for-Hypertrophic-Cardiomyopathy 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Activation-helix-orientation-of-estrogen-receptor 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Structural-and-Dynamical-Insight-into-PPAR%CE%B3 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Try-our-outsourcing-services 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/identification-of-P-glycoprotein-binders-based-on-in-house-prepared-diverse-set-of-structures 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/PPAR%CE%B3_helix_12_exhibits_an_antagonist_conformation 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/PPAR%CE%B3_non-covalent_antagonists_exhibit_mutable_binding_modes_with_a_similar_free_energy_of_binding 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Micar-Innovation-Micar21-TOP-8-BioTech-Award-by-Delta-Ventures-and-the-TOP50-of-the-2018-%20Startup-World-Cup-and-Summit-Regional-Finals 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Diplomatic_World 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Micar_Innovation_listed_as_a_Emerging_Players 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Micar_Innovation_is_One_of_250_Companies 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Micar_Innovation_Micar21_is_the_winner_of_%D0%B0_prestigious_award_for_Innovative_enterprise_of_the_year_2018 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/AI-for-Drug-Discovery-Biomarker-Development 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/scientific-publications 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Combination-of-Genetic-Screening-and-Molecular-Dynamics 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Structural-insight-into-the-UNC-45%E2%80%93myosin-complex 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Discovery-of-a-Novel-Selective-PPAR-Ligand-with-Partial-Agonist 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Molecular-Basis-of-Inactive-B-RAFWT-and-B-RAFV600E-Ligand-Inhibition 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Activation-helix-orientation-of-estrogen-receptor-is-mediated-by-receptor-dimerization 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Structural-and-Dynamical-Insight-into-PPAR%CE%B3-Antagonism-In-silico-Study-of-the-Ligand-Receptor-Interactions-of-non-Covalent-Antagonists 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Molecular-dynamics-simulation-of-the-human-estrogen-receptor-alpha 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/PPAR%CE%B3_helix_12_exhibits_an_antagonist_conformation_1 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/PPARy_non-covalent_antagonists_exhibit_mutable_binding_modes_with_a_similar_free_energy_of_binding_A_case_study 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Prediction-of-Accurate-Binding-Modes-using-Combination-of-classical-and-accelerated-Molecular-dynamics-and-Free-Energy-Perturbation-Calculations-An-Application-to-Toxicity-Studies 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/An-Improvement-of-the-Free-Energy-Perturbation-FEPplus-Sampling-Protocol-in-Case-of-Flexible-protein-Ligand-Binding-Sites 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Combination-of-Structural-based-Pharmacophore-and-Docking-Virtual-Screens-An-Efficient-Structure-based-Protocol-for-Lead-Identification 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Prediction-of-Accurate-Binding-Modes-Using-Combination-of-Classical-and-Accelerated-Molecular-Dynamics-and-Free-Energy-Perturbation-Calculations 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Discovery-of-New-Classes-of-Glycine-transporter-2-GlyT2-Inhibitors-and-GlyT2-Selectivity-Studies 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/Awards 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/hippa 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/cookies 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/privacy-policy 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/terms-of-service 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/research-consents 2019-03-20T06:59:45+00:00 0.80 http://micar21.com/scientific-publications.html 2019-03-20T06:59:45+00:00 0.64 http://micar21.com/in-silico-drug-design.html 2019-03-20T06:59:45+00:00 0.64 http://micar21.com/Resources/image/micar21/Discovery-of-a-Novel-Selective-PPAR-Ligand-with-Partial-Agonist.pdf 2015-03-24T16:19:00+00:00 0.64 http://micar21.com/Resources/image/micar21/Activation-helix-orientation-of-estrogen-receptor-is-mediated-by-receptor-dimerization.pdf 2015-04-16T19:02:06+00:00 0.64 http://micar21.com/Resources/image/micar21/Combination-of-Genetic-Screening-and-Molecular-Dynamics.pdf 2015-03-24T16:18:59+00:00 0.64 http://micar21.com/Resources/image/micar21/Structural-insight-into-the-UNC-45–myosin-complex.pdf 2019-03-20T06:59:45+00:00 0.64 http://micar21.com/Resources/image/micar21/Molecular-Basis-of-Inactive-B-RAFWT-and-B-RAFV600E-Ligand-Inhibition.pdf 2015-03-24T16:19:01+00:00 0.64 http://micar21.com/Resources/image/micar21/Molecular%20dynamics%20simulation%20of%20the%20human%20estrogen%20receptor%20alpha_%20contribution%20to%20the%20pharmacophore%20of%20the%20agonists.pdf 2018-02-04T22:01:57+00:00 0.64